
0 plays
NPR reports on this week’s landmark ruling by India’s Supreme Court that means Indian generic drug manufacturers can keep producing affordable medicines for use in developing countries. Learn more about drug patents.
Photo: Hundreds of activists gathered in New Delhi to protest Novartis’s attack on India’s patent laws in 2007. MSF and others continue to oppose the legal case today. India 2007 © MSF
The Novartis Drop the Case Campaign
Yesterday, India’s Supreme Court upheld India’s Patent Act in the face of a seven-year challenge by Swiss pharmaceutical company Novartis.
“This is a huge relief for the millions of patients and doctors in developing countries who depend on affordable medicines from India, and for treatment providers like MSF,“ said Dr. Unni Karunakara, MSF’s international president.
BREAKING NEWS
Novartis has lost its case in Indian Supreme Court today, protecting access to affordable, quality medicines for people in developing countries.